CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chlorpheniramine polistirex; codeine polistirex and what is the scope of freedom to operate?
Chlorpheniramine polistirex; codeine polistirex
is the generic ingredient in three branded drugs marketed by Lannett Co Inc, Fisons, and Tris Pharma Inc, and is included in three NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Chlorpheniramine polistirex; codeine polistirex has twenty-one patent family members in fourteen countries.
Summary for CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
| International Patents: | 21 |
| US Patents: | 2 |
| Tradenames: | 3 |
| Applicants: | 3 |
| NDAs: | 3 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX |
| DailyMed Link: | CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Anatomical Therapeutic Chemical (ATC) Classes for CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
US Patents and Regulatory Information for CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fisons | PENNTUSS | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 018928-001 | Aug 14, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Tris Pharma Inc | TUZISTRA XR | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 207768-001 | Apr 30, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Tris Pharma Inc | TUZISTRA XR | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 207768-001 | Apr 30, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Fisons | PENNTUSS | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 018928-001 | Aug 14, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | 2009530298 | ⤷ Sign Up | |
| European Patent Office | 2428205 | Formulations à libération modifiée contenant des complexes médicament - résine échangeuse d'ions (Modified release formulations containing drug-ion exchange resin complexes) | ⤷ Sign Up |
| South Korea | 20080108520 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG - ION EXCHANGE RESIN COMPLEXES | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
